secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-05-23T23:59:59+00:00
Accession:  0001493152-23-018725
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 2.03, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX (AGE) receives NYSE American delisting notice; intends to appeal
---------------------------------------------------------------------

- NYSE American intends to delist AgeX for failing stockholders' equity requirements (below $2M, $4M, $6M thresholds) and losses.
- AgeX intends to appeal to a Committee of the Exchange's Board; appeal will stay delisting proceedings pending decision.
- If delisted, AgeX plans to have its common stock quoted on an electronic interdealer quotation system (e.g., OTC).
- AgeX drew $500,000 on its Secured Note with Juvenescence on May 19; repayment due Feb 14, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223018725/0001493152-23-018725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223018725/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-018725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer